Removing Bias in Sampling and Bioinformatics Techniques
Navigating Regulatory Pathways for Your Microbiome Products
Development Process Technologies: From Bench to Bedside
Exploring The Gut-Lung Axis
Market Trends and Investment: Beyond the Money
Developing Synthetically Engineered Pharmabiotics
Discovering the Human Urogenital Microbiome
The Latest Innovations from Industry and Academia
Advancing Applied Microbiome Research
Call for Abstracts Now Open
Pharmabiotics 2019 focuses on the science and business of new research and technologies for treating diseases and sustaining health via the Human Microbiota.
If you are an expert in the field, either from Academia or Industry and have research to present (verbal or poster), we would like to hear from you!
Please complete the form on the right, following the specified guidelines:
Abstract Submission Guidelines
Only abstracts on recent, original research related to the influence of the microbiota, as well as the analytical tools, therapeutic potential, mechanisms of action, pre-clinical and clinical efficacy in the treatment or prevention of pathologies will be accepted.
Length: Up to 300 words are accepted. Abstracts cannot include tables or figures.
Only standardised abbreviations will be allowed. Any abbreviation should be explained in brackets the first time it appears in the text.
Selection will be carried out on the basis of overall quality of the abstract and special interest by the scientific committee. Abstract acceptance or rejection will be notified by e-mail along with presentation criteria and other details.
The scientific committee reserves the rights to reject proposals that are beyond the scope of the conference.
Submissions imply the intent of at least one author to register, attend the conference and present the study. The author has to be registered before January 31st 2019.